These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11033183)

  • 1. Targeting tumor blood vessels: an adjuvant strategy for radiation therapy.
    Siemann DW; Warrington KH; Horsman MR
    Radiother Oncol; 2000 Oct; 57(1):5-12. PubMed ID: 11033183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the tumor vasculature: a strategy to improve radiation therapy.
    Siemann DW; Horsman MR
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):321-7. PubMed ID: 15056061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy.
    Siemann DW; Shi W
    Semin Radiat Oncol; 2003 Jan; 13(1):53-61. PubMed ID: 12520464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of radiation therapy by vascular targeting agents.
    Siemann DW; Horsman MR
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1660-5. PubMed ID: 12476970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the tumor vasculature and oxygenation to improve therapy.
    Siemann DW; Horsman MR
    Pharmacol Ther; 2015 Sep; 153():107-24. PubMed ID: 26073310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raising the bar: how HIF-1 helps determine tumor radiosensitivity.
    Moeller BJ; Dewhirst MW
    Cell Cycle; 2004 Sep; 3(9):1107-10. PubMed ID: 15326390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular tumor targeting.
    Ahlskog J; Paganelli G; Neri D
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):296-309. PubMed ID: 17043627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provascular strategy: targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment.
    Sonveaux P
    Radiother Oncol; 2008 Mar; 86(3):300-13. PubMed ID: 18313779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculature and microenvironmental gradients: the missing links in novel approaches to cancer therapy?
    Denekamp J; Daşu A; Waites A
    Adv Enzyme Regul; 1998; 38():281-99. PubMed ID: 9762359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
    Choy H; Milas L
    J Natl Cancer Inst; 2003 Oct; 95(19):1440-52. PubMed ID: 14519750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular strategies for enhancing tumour response to radiation therapy.
    El Kaffas A; Tran W; Czarnota GJ
    Technol Cancer Res Treat; 2012 Oct; 11(5):421-32. PubMed ID: 22568629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways.
    Wachsberger P; Burd R; Dicker AP
    Hematol Oncol Clin North Am; 2004 Oct; 18(5):1039-57, viii. PubMed ID: 15474334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of including spatially longitudinal heterogeneities of vessel oxygen content and vascular fraction in 3D tumor oxygenation models on predicted radiation sensitivity.
    Lagerlöf JH; Kindblom J; Bernhardt P
    Med Phys; 2014 Apr; 41(4):044101. PubMed ID: 24694162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis inhibitors and radiotherapy].
    Riesterer O
    Praxis (Bern 1994); 2012 Aug; 101(16):1031-7. PubMed ID: 22878946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic therapy: creating a unique "window" of opportunity.
    Lin MI; Sessa WC
    Cancer Cell; 2004 Dec; 6(6):529-31. PubMed ID: 15607955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
    Horsman MR; Siemann DW
    Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy.
    Kunjachan S; Detappe A; Kumar R; Ireland T; Cameron L; Biancur DE; Motto-Ros V; Sancey L; Sridhar S; Makrigiorgos GM; Berbeco RI
    Nano Lett; 2015 Nov; 15(11):7488-96. PubMed ID: 26418302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiobiology and vascular targeting in glioma.
    Short SC; Harney J
    Curr Opin Neurol; 2003 Dec; 16(6):651-5. PubMed ID: 14624072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.